ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,912Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1469

$1.01M Total Retail Price of All Prescriptions

Rank: 30 out of 1469

1,374 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 1,310 1,224 235 1 4
AMLODIPINE BESYLATE 1,297 1,204 264 2 3
CARVEDILOL 1,130 971 240 3 2
ATORVASTATIN CALCIUM 926 838 215 4 1
LISINOPRIL 890 734 177 5 7
ATENOLOL 860 780 191 6 12
FUROSEMIDE 798 721 188 7 8
LOSARTAN POTASSIUM 753 689 186 8 11
WARFARIN SODIUM 594 552 122 9 9
CLOPIDOGREL 581 496 123 10 5
KLOR-CON 8 500 466 119 10 11 73
AMIODARONE HCL 401 372 90 12 20
BENAZEPRIL HCL 329 304 70 13 26
SIMVASTATIN 327 264 68 14 6
ISOSORBIDE MONONITRATE ER 273 208 55 15 13
CRESTOR 257 230 60 16 15
PRAVASTATIN SODIUM 253 227 51 17 19
AMLODIPINE BESYLATE-BENAZEPRIL 210 176 36 18 74
POTASSIUM CHLORIDE 190 159 46 19 18
DIOVAN 182 177* 40 20 14
OMEPRAZOLE 179 164 36 21 23
ZETIA 165 160* 38 22 27
METOPROLOL TARTRATE 161 147 44 23 10
DILTIAZEM 24HR ER 160 155* 32 24 38
HYDRALAZINE HCL 145 113 34 25 36
CLONIDINE HCL 141 129 35 26 43
FENOFIBRATE* 140 116 26 27 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 100 29 28 91
LEVOTHYROXINE SODIUM 127 96 22 29 21
CILOSTAZOL 125 120* 26 30 93
TRIAMTERENE-HYDROCHLOROTHIAZID 117 96 41 31 175
NIASPAN 113 82 29 32 62
NITROSTAT 111 106* 83 33 30
DILTIAZEM 24HR CD 107 102* 23 34 67
DILTIAZEM ER 105 100* 33 35 90
METOLAZONE 105 100* 27 35 115
LOSARTAN-HYDROCHLOROTHIAZIDE 104 69 29 37 32
PRADAXA 104 99* 24 37 28
PROPAFENONE HCL 101 96* 23 39 56
SPIRONOLACTONE 99 59 25 40 22
HYDROCHLOROTHIAZIDE 96 91* 23 41 16
XARELTO 95 95 20 42 24
DILTIAZEM HCL 89 84* 17 43 145
KLOR-CON 10 88 83* 21 44 105
PANTOPRAZOLE SODIUM 88 83* 21 44 41
VALSARTAN-HYDROCHLOROTHIAZIDE 83 62 16 46 37
BYSTOLIC 73 55 16 47 29
LOVASTATIN 72 67* 12 48 40
BENICAR 64 52 12 49 49
FENOFIBRATE* 56 <11 <11 50 54
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.